• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特定人群中真性红细胞增多症的发病率。

Incidence of polycythemia vera in a defined population.

作者信息

Berglund S, Zettervall O

机构信息

Department of Medicine, University of Lund, Malmö General Hospital, Sweden.

出版信息

Eur J Haematol. 1992 Jan;48(1):20-6. doi: 10.1111/j.1600-0609.1992.tb01788.x.

DOI:10.1111/j.1600-0609.1992.tb01788.x
PMID:1730276
Abstract

In this retrospective investigation from Malmö, a city well-suited for epidemiologic studies, 177 patients (88 males and 89 females) with polycythemia vera (PV) were identified between 1950 and 1984. The incidence rate (number of cases/100,000/yr) in both sexes increased significantly, being 1.0 in 1950-1959 and 2.6 in 1980-1984 (adjusted to the European age-standardized population). This is the highest rate reported to date. In 1970-1984 the highest age-specific incidence rates (number of cases/100,000/yr) were found in males greater than or equal to 80 yr and females 70-79 yr of age, being 18.3 and 14.6, respectively. A subgroup of 12 (7%) was identified where the PV diagnosis was not obvious on entry into the study but where it became clear during follow-up. 16 PV patients (9%) had verified or suspected arterial hypoxemia caused by a concomitant condition. We conclude that the increasing PV incidence rates, mainly confined to older age groups, are probably due to better case ascertainment.

摘要

在马尔默市进行的这项回顾性调查中,马尔默是一个非常适合进行流行病学研究的城市,在1950年至1984年期间共识别出177例真性红细胞增多症(PV)患者(88例男性和89例女性)。两性的发病率(病例数/10万/年)均显著增加,1950 - 1959年为1.0,1980 - 1984年为2.6(根据欧洲年龄标准化人口进行调整)。这是迄今为止报告的最高发病率。1970 - 1984年,年龄特异性发病率最高(病例数/10万/年)的是80岁及以上男性和70 - 79岁女性,分别为18.3和14.6。有12例(7%)患者在进入研究时PV诊断不明显,但在随访期间明确诊断。16例PV患者(9%)因并发疾病导致动脉血氧不足得到证实或怀疑。我们得出结论,PV发病率的增加主要局限于老年人群体,可能是由于病例确诊率提高所致。

相似文献

1
Incidence of polycythemia vera in a defined population.特定人群中真性红细胞增多症的发病率。
Eur J Haematol. 1992 Jan;48(1):20-6. doi: 10.1111/j.1600-0609.1992.tb01788.x.
2
Polycythemia Vera.真性红细胞增多症。
Curr Treat Options Oncol. 2018 Mar 7;19(2):12. doi: 10.1007/s11864-018-0529-x.
3
Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992.
Eur J Haematol. 2000 Oct;65(4):267-71. doi: 10.1034/j.1600-0609.2000.065004267.x.
4
Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage.真性红细胞增多症中的白细胞增多和特发性血小板增多症中的脾肿大是出血的独立危险因素。
Eur J Haematol. 2013 Mar;90(3):228-36. doi: 10.1111/ejh.12064.
5
Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.1983年至1999年期间瑞典哥德堡市慢性费城染色体阴性(Ph-)骨髓增殖性疾病的发病率趋势。
J Intern Med. 2004 Aug;256(2):161-5. doi: 10.1111/j.1365-2796.2004.01357.x.
6
Polycythemia vera and essential thrombocythemia in young patients.年轻患者的真性红细胞增多症和原发性血小板增多症。
Haematologica. 1993 Nov-Dec;78(6 Suppl 2):11-7.
7
Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany.临床实践中真性红细胞增多症患者的特征与治疗:对德国1476例个体的多中心病历回顾
J Cancer Res Clin Oncol. 2016 Sep;142(9):2041-9. doi: 10.1007/s00432-016-2209-1. Epub 2016 Jul 18.
8
Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989.
Am J Hematol. 1994 Oct;47(2):89-93. doi: 10.1002/ajh.2830470205.
9
Inapparent polycythemia vera: an unrecognized diagnosis.隐匿性真性红细胞增多症:一种未被识别的诊断。
Am J Med. 1997 Jan;102(1):14-20. doi: 10.1016/s0002-9343(96)00351-8.
10
Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.真性红细胞增多症和原发性血小板增多症中的原始细胞转化和纤维化进展:发病率及危险因素的文献综述
Blood Cancer J. 2015 Nov 13;5(11):e366. doi: 10.1038/bcj.2015.95.

引用本文的文献

1
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.放血疗法对低危真性红细胞增多症患者生活质量的影响。
J Clin Med. 2024 Aug 22;13(16):4952. doi: 10.3390/jcm13164952.
2
Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden.基于人群的瑞典研究中骨髓增殖性肿瘤的发病率 - 亚组和年龄趋势。
J Intern Med. 2020 Apr;287(4):448-454. doi: 10.1111/joim.13019. Epub 2020 Jan 11.
3
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.
2001 - 2012年美国骨髓增殖性肿瘤和骨髓增生异常/骨髓增殖性肿瘤的发病率及患者生存率
Br J Haematol. 2016 Aug;174(3):382-96. doi: 10.1111/bjh.14061. Epub 2016 Apr 7.
4
New Therapeutic Approaches in Polycythemia Vera.真性红细胞增多症的新治疗方法
Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl(0):S27-33. doi: 10.1016/j.clml.2015.02.013.
5
Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?持续性红细胞增多症是否有必要进行骨髓活检检查?
Curr Hematol Malig Rep. 2006 Jun;1(2):87-92. doi: 10.1007/s11899-006-0028-1.
6
Use and risks of phosphorus-32 in the treatment of polycythaemia vera.
Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1413-7. doi: 10.1007/s00259-003-1270-6. Epub 2003 Sep 3.
7
Polycythaemia vera and essential thrombocythaemia in the elderly.老年人真性红细胞增多症和原发性血小板增多症
Drugs Aging. 2000 Aug;17(2):107-19. doi: 10.2165/00002512-200017020-00003.